Darmstadt
-
Merck announces update on INTR@PID Lung 037 study
The comprehensive INTR@PID programme is designed to assess the impact of bintrafusp alfa across distinct cancers Merck, Darmstadt, Germany, announced…
Read More »
The comprehensive INTR@PID programme is designed to assess the impact of bintrafusp alfa across distinct cancers Merck, Darmstadt, Germany, announced…
Read More »